Loading articles...
Patients with atopic dermatitis (AD) are benefiting from the shift toward targeted systemic therapies that avoid broad immunosuppression. The evolution towards biologics and JAK inhibitors promises more precise management and fewer off-target effects, thoug...
Rising Staphylococcus aureus resistance in atopic dermatitis threatens the effectiveness of common topical treatments. This demands a reevaluation of antimicrobial stewardship programs to preserve treatment options and reduce healthcare costs.
Rising antibiotic resistance in Staphylococcus aureus complicates atopic dermatitis treatment. This UK study prompts a re-evaluation of first-line topical therapies to preserve their effectiveness.
Atopic dermatitis treatment is being complicated by the changing face of antimicrobial resistance. Clinicians need to anticipate further shifts in resistance patterns to maintain effective treatment strategies, especially regarding topical agents.